Mark Schrader - Concepedia

Author

Mark Schrader

Charité - Universitätsmedizin Berlin ORCID

Also Known As

M Schrader, M. Schrader, MARK SCHRADER, Mark G Schrader, Mark G. Schrader, Mark Schrader, Michael Stöckle, Schrader, Mark

234

Publications

6.3K

Citations

H-Index

119

Concepts

All Affiliations

Charité - Universitätsmedizin Berlin Universität Ulm Freie Universität Berlin Universität Hamburg Franklin University

About

Mark Schrader is an author at Charité - Universitätsmedizin Berlin specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	48	3.4K
2	Public Health	6	6	156
3	Engineering	3	3	324
4	Health Sciences	3	3	554
5	Natural Sciences	1	1	88

Mark Schrader

Publications

Citations

H-Index

Page 1

	Year	Citations
Activation of Transient Receptor Potential Vanilloid Type-1 Channel Prevents Adipogenesis and Obesity Lili Zhang, Dao Yan Liu, Qun Li, Circulation Research Visceral Adipose TissueTrpv1 ChannelsCellular PhysiologyObesityMetabolic Syndrome	2007	405
Enzalutamide in Castration-resistant Prostate Cancer Patients Progressing After Docetaxel and Abiraterone Andres Jan Schrader, Martin Boegemann, Carsten-H. Ohlmann, European Urology UrologyOncologyMedicineBenign Prostatic HyperplasiaPharmacotherapy	2013	285
Fluorescent methylation-specific polymerase chain reaction for DNA-based detection of prostate cancer in bodily fluids. Carsten Goessl, Hans Krause, Markus Müller, PubMed EngineeringDna AnalysisMolecular BiologyPathologyNucleic Acid Amplification Test	2000	276
European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A Report of the Second Meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): Part II S. Krege, J. Beyer, Rainer Souchon, European Urology Germ Cell CancerGenitourinary CancerMedicineCancer ManagementEuropean Consensus Conference	2008	252
Sarcosine in Urine after Digital Rectal Examination Fails as a Marker in Prostate Cancer Detection and Identification of Aggressive Tumours Florian Jentzmik, Carsten Stephan, Kurt Miller, European Urology UrologySurgical OncologyAggressive TumoursMedicineBenign Prostatic Hyperplasia	2010	231
Expression levels of the EZH2 polycomb transcriptional repressor correlate with aggressiveness and invasive potential of bladder carcinomas Steffen Weikert, Frank Christoph, Jens Köllermann, International Journal of Molecular Medicine Bladder CarcinomasCancer BiologyTumor BiologyTranscriptional RegulationGenitourinary Cancer	2005	151
DNA-based detection of prostate cancer in urine after prostatic massage Carsten Goessl, Markus Müller, Rüdiger Heicappell, Urology UrologyGenitourinary CancerMedicineDna ReplicationPathology	2001	149
Incidence and long-term prognosis of papillary compared to clear cell renal cell carcinoma – A multicentre study Sandra Steffens, Martin Janssen, Frederik C. Roos, European Journal of Cancer A Multicentre StudyUrologySurgical OncologyGenitourinary CancerMedicine	2012	142
Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis Steffen Weikert, Frank Christoph, Mark Schrader, International Journal of Cancer PathologySurvivin MrnaTumor BiologyGenitourinary CancerQuantitative Analysis	2005	105
Does Obesity Influence the Prognosis of Metastatic Renal Cell Carcinoma in Patients Treated with Vascular Endothelial Growth Factor–Targeted Therapy? Sandra Steffens, Viktor Grünwald, Kristina I. Ringe, The Oncologist	2011	100

Page 1